Physician profile
Robert G Solyomvari
NPI 1992750012
$11,460.48
in general payments reported to CMS, 2019-2025
33 companies · $631 in 2025
The $631 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,923 · 2020: $256 · 2021: $47.98 · 2022: $6,283 · 2023: $2,042 · 2024: $278 · 2025: $631.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,802 · Travel and Lodging: $1,132 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,801.94 |
| Travel and Lodging | $1,131.84 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,392.03 | 2022-2024 | Da Vinci Surgical System |
| Philips North America LLC | $1,684.76 | 2019-2022 | |
| Cook Incorporated | $1,131.84 | 2023 | Zilver Vena |
| Endologix LLC | $1,004.48 | 2020-2025 | Afx2 Bifurcated Endograft System, Alto Abdominal Stent Graft System, Endocross Device |
| Shockwave Medical, INC | $152.04 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Lemaitre Vascular, INC. | $139.78 | 2019-2024 | Artegraft Vascular Graft |
| Molnlycke Health Care US, LLC | $88.10 | 2023-2024 | Mepilex Border Post-Op Ag, Avance, Mepilex Border Sacrum |
| Boston Scientific Corporation | $82.82 | 2020 | |
| Abbott Laboratories | $73.35 | 2019-2025 | Esprit |
| W. L. Gore & Associates, INC. | $70.05 | 2021-2024 | Gore Propaten Vascular Graft, Gore Viabahn Endoprosthesis With Heparin |
| Allergan, INC. | $58.88 | 2019-2022 | |
| Davol INC. | $47.64 | 2019 | |
| Solventum Corporation | $47.15 | 2024-2025 | Prevena, V.A.C. Veraflo, V.A.C.Ulta |
| Cardiovascular Systems INC. | $37.43 | 2020-2022 | |
| Cook Medical LLC | $36.22 | 2020-2025 | Cook Celect |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $35.64 | 2019-2023 | V.A.C.Ulta, Prevena, V.A.C. Veraflo |
| Covidien LP | $30.92 | 2019 | |
| Conmed Corporation | $29.02 | 2025 | Conmed Specimen Retrieval, Airseal |
| Biom'Up France Sas | $28.79 | 2020 | |
| Ethicon US, LLC | $28.63 | 2023 | Ethicon, Surgicel Nu-Knit, Surgiflo Hemostatic Matrix |
| Vertex Pharmaceuticals Incorporated | $25.37 | 2025 | |
| Medtronic, INC. | $25.01 | 2025 | In.Pact Av |
| Sanara Medtech INC. | $24.75 | 2025 | Celleraterx |
| Bioventus LLC | $23.22 | 2022 | |
| Innocoll Pharmaceuticals Limited | $22.75 | 2022 | |
| Tactile Systems Technology INC | $21.14 | 2019 | |
| Becton, Dickinson and Company | $20.21 | 2023 | Phasix Mesh |
| Bard Peripheral Vascular, INC. | $19.39 | 2019 | |
| Organogenesis INC. | $17.79 | 2023 | Puraply |
| Pacira Pharmaceuticals Incorporated | $17.72 | 2025 | Exparel |
| Angiodynamics, INC. | $16.32 | 2022 | |
| Dilon Technologies, INC. | $14.70 | 2023 | Hemoblast Bellows |
| Reprise Biomedical, INC. | $12.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Solyomvari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.